|
Market Closed -
Other stock markets
|
After market 11:20:00 am | |||
| 866.8 DKK | -1.35% |
|
866.8 | 0.00% |
| 04:20pm | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
| 12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk on Wednesday lifted its sales and operating profit outlook for the year on the back of strong first-half earnings.
Novo Nordisk now expects sales growth of 12-16% at constant exchange rates, up from a previous estimate of 10-14%. It forecasts operating profit to grow 11-15%, versus an earlier estimate of 9-13%.
(Reporting by Nikolaj Skydsgaard; Editing by David Goodman)
| 1st Jan change | Capi. | |
|---|---|---|
| +24.17% | 562B | |
| -6.41% | 358B | |
| +19.78% | 322B | |
| +7.64% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.21% | 149B | |
| -6.51% | 146B | |
| +2.07% | 117B |
NOVO NORDISK A/S 
